UK Supreme Reports H1 2024: Vape Sales Drop 13%, ELFBAR & LOST MARY Revenue Hits £30.3M

Nov.28.2024
UK Supreme Reports H1 2024: Vape Sales Drop 13%, ELFBAR & LOST MARY Revenue Hits £30.3M
UK vape distributor Supreme's H1 2024 report shows total revenue up 8% to £113 million. Vape category revenue fell 13% due to the upcoming ban on disposable vapes, while ELFBAR and LOST MARY brand sales grew to £30.3 million.

The UK e-cigarette distributor Supreme has released its half-yearly financial report for the period ending on September 30th. The report shows that revenue increased by 8%, reaching £113 million, compared to £105.1 million for the same period last year, according to a report by Asian Trader on November 27th.

 

Key highlights from the report:

 

  • Vape category revenue was £36.6 million, a 13% drop from £42.1 million last year, mainly due to strategic adjustments ahead of the disposable vape ban set for June 2025.

 

  • Sales of disposable vapes fell by 56% to £4.4 million, while non-disposable product revenue remained steady at £32.2 million.

 

  • Revenue from ELFBAR and LOST MARY disposable vapes totaled £30.3 million, a 15% increase compared to just three months of distribution last year.

 

  • Adjusted EBITDA grew by 22% to £18.5 million, driven by improved gross margins and tight cost control.

 

  • Supreme's non-vape annual revenue now exceeds £100 million, representing about 45% of total revenue.

 

The company also emphasized its shift towards the 88Nic brand, focusing on rechargeable pod systems, 10ml e-liquid refills, and nicotine pouches. These moves align with expected regulatory changes and further underscore Supreme's long-term commitment to supporting vaping as a smoking cessation tool.

 

The company CEO, Sandy Chadha, said: "The strength of our strategy and the proactivity of our teams means we are well-positioned for upcoming changes in the UK vaping sector. Non-disposable vapes account for the majority of our vaping revenue, and we continue to report growth in 10ml e-liquid refills."

 

"Adding well-recognized and trusted brands into Supreme's unrivaled distribution network across UK retail is central to our long-term growth strategy, and this acquisition reaffirms our ability to identify and execute quickly on M&A opportunities."

 

"We have experienced steady growth across our categories whilst seamlessly diversifying our portfolio through the acquisition of Clearly Drinks," Chadha said. "Through the acquisition of Clearly Drinks, we have achieved steady growth across our various product categories while also diversifying our product portfolio. Bringing a well-known and trusted brand into Supreme's distribution network in the UK retail sector is a core part of our long-term growth strategy, and this acquisition once again demonstrates our ability to quickly identify and execute merger and acquisition opportunities.

 

Supreme is projecting revenue of approximately £240 million for the 2025 fiscal year, with adjusted EBITDA of at least £40 million, thanks to sustained strong growth in its core categories and continued market adaptability.

 

Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
DOJO officially launched the BLAST7K Fresh on September 17, 2026, introducing a UK-market prefilled pod product with 6ml of e-liquid and a manufacturer-rated capacity of up to 7,000 puffs. The device features a 1000mAh rechargeable battery, the INSTA-JUICED structure and COREX BLAST dual-mesh technology, while retaining compatibility with existing BLAST pods. The launch comes less than two weeks before the UK's Vaping Products Duty takes effect on October 1. At the new duty rate, 6ml of vaping liquid would correspond to £1.32 in VPD. DOJO has not stated that the product's 6ml format was designed in response to the new duty.
Sep.20
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
China’s HTP Exports Fell 14.3% in H1 2026 as Russia and Belarus Accounted for 76% Lead
China’s HTP Exports Fell 14.3% in H1 2026 as Russia and Belarus Accounted for 76% Lead
In H1 2026, China’s HS 24041100 exports stood at $1.32 million, down 14.3% YoY, with volume falling 17.2% to 55.33 tons. Market distribution shifted drastically amid overall export drops. Exports to Russia and Belarus totaled $1 million, taking 76.0% of all shipments versus 29.5% in H1 2025. Belarus became the top destination with export value jumping 177.5%, while the Philippines, Singapore and Indonesia’s combined share slumped from 49.3% to 11.2%.Domestically, Yunnan led exporter registrations; Jiangsu and Shanghai were key suppliers, yet Anhui and Sichuan had no exports. Heavy concentration means order or declaration changes for Russia/Belarus greatly affect national aggregate data. The data shows customs entry points (not end markets), covering tobacco consumables only, excluding heating equipment and the complete HTP supply chain.
Aug.11
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI nicotine pouch brand Nordic Spirit has entered a long-term partnership with Manchester’s Co-op Live, becoming the venue’s Official Nicotine Pouch Partner. The 23,500-capacity venue is the UK’s largest indoor live entertainment arena. Nordic Spirit will run in-venue activations for existing adult nicotine consumers and sell products at selected arena bars. The agreement was entered into before the relevant UK sponsorship restrictions were introduced, while the government intends to implement a comprehensive ban on advertising and sponsorship of vaping and nicotine products from June 1, 2027.
Sep.07